Literature DB >> 30712969

Consensus in Bladder Cancer Research Priorities Between Patients and Healthcare Professionals Using a Four-stage Modified Delphi Method.

Agustina Bessa1, Steven Maclennan2, Deborah Enting3, Richard Bryan4, Debra Josephs3, Simon Hughes5, Suzanne Amery6, Muhammad Shamim Khan6, Sachin Malde6, Rajesh Nair6, Fidelma Cahill7, Harriet Wylie7, Ramesh Thurairaja6, Kathryn Chatterton6, Netty Kinsella8, Christel Häggström9, Mieke Van Hemelrijck7.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30712969     DOI： 10.1016/j.eururo.2019.01.031

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  8 in total

1.  Building the Canadian Bladder Cancer Research Network (CBCRN): Progress during a pandemic.

Authors:  Peter C Black; Nimira Alimohamed; Wassim Kassouf; John L Gore; Kathy D McCoy; Brad H Nelson; Daniel D De Carvalho; Rodney J Ouellette; Ferg Devins; Tony Cornacchia; D Robert Siemens; David M Berman; Srikala S Sridhar; Girish Kulkarni
Journal:  Can Urol Assoc J       Date:  2022-06       Impact factor: 2.052

2.  Scoping review protocol: is there a role for physical activity interventions in the treatment pathway of bladder cancer?

Authors:  Sneha Mehrotra; Megan Rowland; Hanyu Zhang; Beth Russell; Louis Fox; Katharina Beyer; Elke Rammant; Nicola Peat; Mieke Van Hemelrijck; Cecilia Bosco
Journal:  BMJ Open       Date:  2019-11-12       Impact factor: 2.692

3.  Is there a role for physical activity interventions in the treatment pathway of bladder cancer? A scoping review of the literature.

Authors:  Agustina Bessa; Cecilia Bosco; Sneha Mehrotra; Megan Rowland; Hanyu Zhang; Beth Russell; Louis Fox; Katharina Beyer; Elke Rammant; Suzanne Amery; Kathryn Chatterton; Nicola Peat; Christel Haggstrom; Mieke Van Hemelrijck
Journal:  BMJ Open Sport Exerc Med       Date:  2021-03-10

4.  STAG2 Protein Expression in Non-muscle-invasive Bladder Cancer: Associations with Sex, Genomic and Transcriptomic Changes, and Clinical Outcomes.

Authors:  Naheema S Gordon; Nada Humayun-Zakaria; Anshita Goel; Ben Abbotts; Maurice P Zeegers; K K Cheng; Nicholas D James; Roland Arnold; Richard T Bryan; Douglas G Ward
Journal:  Eur Urol Open Sci       Date:  2022-03-04

5.  Genetic Testing and Its Clinical Application in Prostate Cancer Management: Consensus Statements from the Hong Kong Urological Association and Hong Kong Society of Uro-Oncology.

Authors:  Peter K F Chiu; Eric K C Lee; Marco T Y Chan; Wilson H C Chan; M H Cheung; Martin H C Lam; Edmond S K Ma; Darren M C Poon
Journal:  Front Oncol       Date:  2022-07-18       Impact factor: 5.738

6.  Cohort profile: King's Health Partners bladder cancer biobank.

Authors:  Pinky Kotecha; Charlotte L Moss; Deborah Enting; Cheryl Gillett; Magdalene Joseph; Debra Josephs; Sarah Rudman; Simon Hughes; Fidelma Cahill; Harriet Wylie; Anna Haire; James Rosekilly; Muhammad Shamin Khan; Rajesh Nair; Ramesh Thurairaja; Sachin Malde; Mieke Van Hemelrijck
Journal:  BMC Cancer       Date:  2020-09-25       Impact factor: 4.430

7.  Massively parallel sequencing of urinary DNA-the dawn of non-invasive bladder cancer detection and surveillance?

Authors:  Douglas G Ward; Richard T Bryan
Journal:  Transl Cancer Res       Date:  2019-03       Impact factor: 1.241

8.  Stromal marker fibroblast activation protein drives outcome in T1 non-muscle invasive bladder cancer.

Authors:  Tim Muilwijk; Murat Akand; Sofie Daelemans; Koen Marien; Yannick Waumans; Mark Kockx; Loïc Baekelandt; Thomas Van den Broeck; Frank Van der Aa; Thomas Gevaert; Steven Joniau
Journal:  PLoS One       Date:  2021-09-15       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.